Skip to main content

Table 4 Treatment response between GCB subgroup and non-GCB subgroups in HBsAg-positive and -negative DLBCL patients

From: Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China

Treatment response HBsAg-positive patients HBsAg-negative patients
GCB (n = 47) non-GCB (n = 79) P-Value GCB (n = 107) non-GCB (n = 186) P value
CR/CRu 42 46 0.252 73 123 0.718
PR 15 27   29 54  
SD 0 1   2 2  
PD 3 5   3 7  
  1. CR complete response, PR partial response, SD stable disease, PD progressive disease